RxDoctor Payments Data

Brian Snyder, MD

Neurological Surgery · Madison, WINPI 1689081895

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Si-bone, Inc. at 28.2% of the total. Reporting peaked in 2021 at $3,097 and has fallen 79.2% since, to $645 in 2025.

$8,739in general payments, 2019–2025

Across 104 payments — averaging $84.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$2K
  • Medtronic$2K
  • Medical Device Business Services, Inc.$1K
  • Globus Medical$1K
  • Johnson & Johnson$623
  • Nevro Corp.$406
  • plus $842 from 17 others

What the payments were for

  • Travel & lodging$3,40939%
  • Food & beverage$4,28349%
  • Education$1,04712%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,739 in reported general payments places this provider in the 80th percentile of 133 neurological surgery providers in Wisconsin.

See all neurological surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$37,527
Medicare patients
82
Services billed
141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin24$170

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →